Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07415902
Eligibility Criteria:
Inclusion Criteria:
* Age: ≥18 years old, regardless of gender;
* Presence of symptomatic coronary heart disease or objective clinical evidence of myocardial ischemia;
* Treated with DCB for one of the following lesions: in-stent restenosis (any stent type) or de novo lesions with a reference vessel diameter of ≥2.0 mm and ≤2.75 mm.
Exclusion Criteria:
* Residual stenosis \>30% after pre-treatment with type C or higher dissection;
* A history of cardiogenic shock;
* Severe congestive heart failure or NYHA class IV severe heart failure;
* Pregnant or lactating women;
* Life expectancy ≤24 months (e.g., patients with extensive metastatic malignant tumors).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07415902
Study Brief:
Protocol Section:
NCT07415902